Related Experiment Video
Updated: May 8, 2026

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
Active DNA demethylation in post-mitotic neurons: a reason for optimism
David P Gavin1, Kayla A Chase2, Rajiv P Sharma1
1The Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 W. Taylor St., Chicago, IL 60612, USA; Jesse Brown Veterans Affairs Medical Center, 820 South Damen Avenue (M/C 151), Chicago, IL 60612, USA.
Abstract:
Over the last several years proteins involved in base excision repair (BER) have been implicated in active DNA demethylation. We review the literature supporting BER as a means of active DNA demethylation, and explain how the various components function and cooperate to remove the potentially most enduring means of epigenetic gene regulation. Recent evidence indicates that the same pathways implicated during periods of widespread DNA demethylation, such as the erasure of methyl marks in the paternal pronucleus soon after fertilization, are operational in post-mitotic neurons. Neuronal functional identities, defined here as the result of a combination of neuronal subtype, location, and synaptic connections are largely maintained through DNA methylation. Chronic mental illnesses, such as schizophrenia, may be the result of both altered neurotransmitter levels and neurons that have assumed dysfunctional neuronal identities. A limitation of most current psychopharmacological agents is their focus on the former, while not addressing the more profound latter pathophysiological process. Previously, it was believed that active DNA demethylation in post-mitotic neurons was rare if not impossible. If this were the case, then reversing the factors that maintain neuronal identity, would be highly unlikely. The emergence of an active DNA demethylation pathway in the brain is a reason for great optimism in psychiatry as it provides a means by which previously pathological neurons may be reprogrammed to serve a more favorable role. Agents targeting epigenetic processes have shown much promise in this regard, and may lead to substantial gains over traditional pharmacological approaches.
Insights
Base excision repair (BER) proteins drive active DNA demethylation, reprogramming dysfunctional neurons. This epigenetic pathway offers new hope for treating chronic mental illnesses like schizophrenia by targeting neuronal identity.
Area of Science:
- Epigenetics
- Neuroscience
- Molecular Biology
Background:
- DNA methylation is a key epigenetic regulator of neuronal identity.
- Chronic mental illnesses may involve dysfunctional neuronal identities maintained by DNA methylation.
- Active DNA demethylation in post-mitotic neurons was previously considered unlikely.
Purpose of the Study:
- To review the role of base excision repair (BER) proteins in active DNA demethylation.
- To explain the mechanism of BER-mediated DNA demethylation in neurons.
- To discuss the therapeutic potential of targeting epigenetic processes in psychiatry.
Main Methods:
- Literature review of studies on BER and DNA demethylation.
- Analysis of evidence for BER pathway operation in post-mitotic neurons.
- Discussion of implications for neuronal identity and mental illness.
Main Results:
- BER proteins are involved in active DNA demethylation, removing epigenetic marks.
- The BER pathway is active in post-mitotic neurons, challenging previous assumptions.
- This pathway can reprogram dysfunctional neuronal identities.
Conclusions:
- Active DNA demethylation via BER in neurons provides a mechanism for reversing pathological changes.
- Targeting epigenetic processes offers a promising therapeutic strategy for mental illnesses.
- This approach may lead to significant advancements over traditional psychopharmacology.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Somatic to iPS Cell Reprogramming

